Combining ONYX-015 with Radiation Therapy for Brain Tumors
Author Information
Author(s): Geoerger B, Grill J, Opolon P, Morizet J, Aubert G, Lecluse Y, van Beusechem V W, Gerritsen W R, Kirn D H, Vassal G
Primary Institution: Institut Gustave-Roussy
Hypothesis
Does the oncolytic adenovirus ONYX-015 enhance the effectiveness of radiation therapy in treating malignant gliomas?
Conclusion
The study found that ONYX-015 significantly enhances the antitumor effects of radiation therapy in human malignant glioma xenografts.
Supporting Evidence
- ONYX-015 treatment resulted in significant tumor growth delay compared to controls.
- Combination treatment led to 73% partial tumor regressions in one xenograft model.
- Total body irradiation prior to ONYX-015 treatment showed additive tumor growth delay.
Takeaway
Researchers tested a virus called ONYX-015 to see if it could help radiation therapy work better for brain tumors, and it did!
Methodology
The study involved treating human malignant glioma xenografts in mice with ONYX-015 and radiation therapy, measuring tumor growth and regression.
Potential Biases
Potential bias in the selection of treatment groups and the interpretation of results.
Limitations
The study was conducted in animal models, which may not fully replicate human responses.
Participant Demographics
The study used female SPF-Swiss athymic nude mice bearing human glioma xenografts.
Statistical Information
P-Value
<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website